Adipokines in nonalcoholic fatty liver diseaseStergios A. Pοlyzos, Christos S. Mantzoros, Jannis Kountouras|Metabolism|2015Cited by 353
Circulating leptin in non-alcoholic fatty liver disease: a systematic review and meta-analysisStergios A. Pοlyzos, Christos S. Mantzoros, Konstantinos N. Aronis et al.|Diabetologia|2015Cited by 251
The use of statins alone, or in combination with pioglitazone and other drugs, for the treatment of non-alcoholic fatty liver disease/non-alcoholic steatohepatitis and related cardiovascular risk. An Expert Panel StatementVasilios G. Athyros, Christos S. Mantzoros, Theodore K. Alexandrides et al.|Metabolism|2017Cited by 251
Leptin in nonalcoholic fatty liver disease: A narrative reviewStergios A. Pοlyzos, Christos S. Mantzoros, Jannis Kountouras|Metabolism|2014Cited by 240
Eradication of Helicobacter pylori may be beneficial in the management of Alzheimer’s diseaseJannis Kountouras, Ioannis Venizelos, Marina Boziki et al.|Journal of Neurology|2009Cited by 188